Abbvie Company Profile

Aggregated data from the web about Abbvie

Company Name	Abbvie
Website	https://www.abbvie.com
Snippet	WebAbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
ISIN	US00287Y1091
Type	Public
Founded	2013
Revenue	US$32.753 billion (2018)[1]
Website	abbvie.com
Industry	Biopharmaceutical
Products	Humira (adalimumab), Imbruvica (ibrutinib), Venclexta (venetoclax), Zinbryta (daclizumab), Kaletra (lopinavir), Norvir (ritonavir), Mavyret/Maviret (glecaprevir/pibrentasvir), Skyrizi (risankizumab)
Traded as	NYSE: ABBVS&P 100 componentS&P 500 component
Key people	Richard A. Gonzalez(Chairman and CEO)Michael Severino(Vice Chairman and President)
Net income	US$5.687 billion (2018)[1]
Area served	Worldwide(170+ countries)
Headquarters	Lake Bluff, Illinois, United States
Total assets	US$59.352 billion (2018)[1]
Total equity	–US$8.446 billion (2018)[1]
Operating income	US$6.383 billion (2018)[1]
Number of employees	~30,000 (January 2019)[1]

Abbvie is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.